Active Ingredient (In Each Tablet)
Dimenhydrinate 50 mg
The following Structured Product Label (SPL) was submitted to the FDA by Carilion Materials Management for the product Dimenhydrinate (NDC 68151-1712). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, ask a doctor before use if you have, when using this product, keep out of reach of children., directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Dimenhydrinate 50 mg
Antiemetic
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222).
adults and children 12 years and over
| 1-2 tablets every 4-6 hours; not more than 8 tablets in 24 hours, or as directed by a doctor
|
children 6 years to under 12 years
| 1/2-1 tablet every 6-8 hours; not more than 3 tablets in 24 hours, or as directed by a doctor
|
children 2 years to under 6 years
| 1/4-1/2 tablet every 6-8 hours; not more than 1 1/2 tablets in 24 hours, or as directed by a doctor
|
store at 15° to 30°C (59° to 86°F)
You may report serious side effects to: . 130 Vintage Drive, Huntsville, AL 35811
colloidal silicone dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, stearic acid
* Please review the disclaimer below.